Junji Yamaguchi Selected Research

Myocardial Infarction

1/2022

Local Injection of Hydroxyapatite Electret Ameliorated Infarct Size After Myocardial Infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junji Yamaguchi Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2021 - 03/2015
3	Starvation 01/2019 - 01/2003
2	Hypoxia (Hypoxemia) 01/2022 - 01/2003
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2022 - 07/2017
2	Hemorrhage 08/2018 - 03/2017
2	Atrial Fibrillation 08/2018 - 08/2013
2	Thromboembolism 08/2018 - 11/2017
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018 - 08/2013
2	Venous Thromboembolism 12/2017 - 11/2017
2	Pulmonary Embolism 11/2017 - 08/2013
2	Infections 06/2012 - 11/2009
1	Myocardial Infarction 01/2022
1	Infarction (Infarctions) 01/2022
1	Proteostasis Deficiencies 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Ectopic Junctional Tachycardia 01/2021
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2020
1	Neuroblastoma 01/2020
1	Ventricular Tachycardia 06/2019
1	Cerebellar Diseases (Cerebellar Syndrome) 10/2018
1	Hematoma 04/2018
1	Perinatal Death 03/2018
1	Heart Failure 01/2018
1	Neoplasms (Cancer) 12/2017
1	Antithrombin III Deficiency 11/2017
1	Shock 09/2015
1	Ventricular Fibrillation 09/2015
1	Eosinophilia 09/2014
1	Diffuse Esophageal Spasm (Esophageal Spasm) 09/2014
1	Hypochromic Anemia (Chlorosis) 02/2014
1	Hypersensitivity (Allergy) 08/2013
1	Dehydration (Water Stress) 11/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
3	AnticoagulantsIBA 08/2018 - 11/2017
2	Cathepsin DIBA 01/2022 - 07/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2020
2	SynucleinsIBA 01/2022 - 01/2021
2	SugarsIBA 01/2019 - 01/2003
2	Warfarin (Coumadin)FDA LinkGeneric 08/2018 - 08/2013
2	RivaroxabanIBA 11/2017 - 08/2013
2	Messenger RNA (mRNA)IBA 11/2009 - 12/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	LigandsIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Durapatite (Hydroxylapatite)IBA 01/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	AntioxidantsIBA 01/2020
1	Verapamil (Calan)FDA LinkGeneric 06/2019
1	UbiquitinIBA 01/2019
1	Ligases (Synthetase)IBA 01/2019
1	edoxabanIBA 12/2017
1	Antithrombin IIIIBA 11/2017
1	Heparin (Liquaemin)FDA LinkGeneric 11/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	NucleotidesIBA 03/2015
1	Immunoglobulin E (IgE)IBA 09/2014
1	SteroidsIBA 09/2014
1	Anthocyanins (Anthocyanin)IBA 02/2014
1	ChitinIBA 06/2012
1	ElementsIBA 11/2009
1	ethyleneIBA 11/2009
1	Carrier Proteins (Binding Protein)IBA 11/2009
1	NitrogenIBA 12/2003
1	Ammonium CompoundsIBA 12/2003
1	alpha-AmylasesIBA 01/2003
1	EnzymesIBA 01/2003
1	GibberellinsIBA 01/2003
1	Starch (Cornstarch)IBA 01/2003

Therapy/Procedure

6	Therapeutics 01/2021 - 09/2014
1	Ligation 01/2022
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020
1	Catheter Ablation 08/2018
1	Pericardiectomy 04/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2018
1	Vena Cava Filters (Inferior Vena Cava Filter) 03/2018
1	Contraindications 03/2017
1	Percutaneous Coronary Intervention 09/2015